Arsenal Medical
Upma Sharma, PhD, has a diverse work experience in the field of materials science and engineering. Upma started their career in 2006 at Lyra Therapeutics as a Senior Engineer and later served as a Manager of Materials Science & Engineering and Senior Manager of the same department. In 2012, Upma joined Arsenal Medical as the Director of Materials Science & Engineering. Upma then held the position of Senior Director of Research & Development at the same company from June 2015 to December 2016. In 2017, they returned to Lyra Therapeutics as the Vice President of Research & Development. Recently, in June 2018, Upma was appointed as the President & CEO of Arsenal Medical.
Upma Sharma, PhD has a strong educational background in engineering and bioengineering. Upma completed their Bachelor of Science degree in Chemical Engineering at Purdue University. Following this, they pursued further studies and obtained their Doctor of Philosophy (Ph.D.) degree in Chemical Engineering from Princeton University. Upma's academic achievements did not stop there, as they went on to complete a post-doctoral program in Bioengineering at Rice University. Through their extensive educational journey, Upma has developed a deep understanding and expertise in the fields of chemical engineering and bioengineering.
This person is not in any teams
Arsenal Medical
Arsenal Medical uses conventional biomaterials in unconventional ways to develop novel products that improve local therapy for injury and disease. The company is advancing multiple preclinical programs based on both its two proprietary technology platforms: its therapeutic foam and AxioCore, a novel, high-throughput nanofiber technology.ArsenalMedical is supported by venture funding, as well as grants from the Department of Defense, National Institute of Standards and Technology’s Technology Innovation Program (NIST-TIP), and the Bill & Melinda Gates Foundation. Its investors include Polaris Venture Partners, North Bridge Venture Partners, and Intersouth Partners.